Ronald W Penczek Elevance Health, Inc. (ELV) insider trading activity

ELV Quotes by TradingView

Ronald W Penczek is CAO & Controller of Elevance Health, Inc.. Currently has a direct ownership of 1,764 shares of ELV, which is worth approximately $717,877. The most recent transaction as insider was on Mar 06, 2024, when has been sold 916 shares (Common Stock) at a price of $504.58 per share, resulting in proceeds of $462,195. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 1.76K
0% 3M change
1.29% 12M change
Total Value Held $717,877

Ronald W Penczek Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 06 2024
SELL
Open market or private sale
$462,195 $504.58 p/Share
916 Reduced 34.18%
1,764 Common Stock
Mar 01 2024
SELL
Payment of exercise price or tax liability
$191,159 $499.11 p/Share
383 Reduced 21.38%
1,408 Common Stock
Mar 01 2024
BUY
Grant, award, or other acquisition
-
1,272 Added 32.19%
2,680 Common Stock
Nov 30 2023
SELL
Open market or private sale
$501,304 $475.17 p/Share
1,055 Reduced 37.12%
1,787 Common Stock
Oct 24 2023
SELL
Open market or private sale
$29,078 $454.35 p/Share
64 Reduced 2.2%
2,842 Common Stock
Mar 02 2023
SELL
Payment of exercise price or tax liability
$178,136 $468.78 p/Share
380 Reduced 11.65%
2,882 Common Stock
Mar 01 2023
SELL
Payment of exercise price or tax liability
$30,017 $469.03 p/Share
64 Reduced 3.34%
1,853 Common Stock
Mar 01 2023
BUY
Grant, award, or other acquisition
-
1,409 Added 30.16%
3,262 Common Stock
Mar 03 2022
SELL
Open market or private sale
$1,123,497 $463.68 p/Share
2,423 Reduced 56.02%
1,902 Common Stock
Mar 03 2022
BUY
Exercise of conversion of derivative security
$462,727 $296.81 p/Share
1,559 Added 26.5%
4,325 Common Stock
Mar 02 2022
SELL
Payment of exercise price or tax liability
$24,101 $463.49 p/Share
52 Reduced 1.85%
2,766 Common Stock
Mar 01 2022
SELL
Payment of exercise price or tax liability
$166,604 $451.5 p/Share
369 Reduced 18.34%
1,643 Common Stock
Mar 01 2022
BUY
Grant, award, or other acquisition
-
1,175 Added 29.43%
2,818 Common Stock
Feb 07 2022
SELL
Open market or private sale
$1,252,965 $453.48 p/Share
2,763 Reduced 57.86%
2,012 Common Stock
Feb 07 2022
BUY
Exercise of conversion of derivative security
$675,526 $244.49 p/Share
2,763 Added 36.65%
4,775 Common Stock
Oct 28 2021
SELL
Open market or private sale
$501,400 $436.0 p/Share
1,150 Reduced 36.4%
2,009 Common Stock
Mar 05 2021
SELL
Open market or private sale
$690,588 $333.94 p/Share
2,068 Reduced 39.73%
3,137 Common Stock
Mar 04 2021
SELL
Open market or private sale
$21,679 $323.56 p/Share
67 Reduced 1.27%
5,205 Common Stock
Mar 02 2021
SELL
Payment of exercise price or tax liability
$13,090 $311.66 p/Share
42 Reduced 0.79%
5,272 Common Stock
Mar 01 2021
SELL
Payment of exercise price or tax liability
$254,791 $311.48 p/Share
818 Reduced 25.27%
2,419 Common Stock
Mar 01 2021
BUY
Grant, award, or other acquisition
-
2,895 Added 35.27%
5,314 Common Stock
Nov 09 2020
SELL
Open market or private sale
$396,569 $330.75 p/Share
1,199 Reduced 27.08%
3,229 Common Stock
RWP

Ronald W Penczek

CAO & Controller
Indianapolis, IN

Track Institutional and Insider Activities on ELV

Follow Elevance Health, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ELV shares.

Notify only if

Insider Trading

Get notified when an Elevance Health, Inc. insider buys or sells ELV shares.

Notify only if

News

Receive news related to Elevance Health, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ELV